CVS Health (CVS) UBS Global Healthcare Conference 2017 summary
Event summary combining transcript, slides, and related documents.
UBS Global Healthcare Conference 2017 summary
4 Nov, 2026Digital and clinical integration
Pharmacy differentiation rests on regulation, insurance and physician integration, and patient trust; >95% of prescriptions have insurance coverage, while <15% are dispensed by mail order, a declining share.
Digital tools and an omnichannel approach aim to simplify customer and patient experiences across front-of-store and pharmacy channels.
Programs including Specialty Connect, Pharmacy Advisor, Maintenance Choice, and Transform Diabetes Care connect pharmacy and clinical assets; Transform Diabetes Care aims to bend diabetes treatment costs.
A clinical platform gives pharmacists and technicians responsibility for patient interaction and follow-up; management cited statistically significant performance improvement in clinical and cost outcomes.
PBM and specialty strategy
2016 pharmacy trend was 3.2% YoY, the lowest in some time; 38% of clients had negative YoY trend. RxInsights can identify savings and support program implementation within a couple of months.
Specialty management focuses on appropriate medication use, patient engagement, formulary management, and getting the right drug to the right patient at the right price.
More than 90% of rebates are passed to clients; plans can use them to reduce premiums or apply them at point of sale, with flexibility to support different plan objectives.
Generics were 87% of prescriptions dispensed; management pointed to 4,000 potential drug approvals in the FDA backlog, many of them generics.
Medicare and network strategy
SilverScript had 5.5M members, versus ~5M at the start of 2016; its low-premium, zero-deductible design and four-star performance for two years were cited as growth advantages.
The Optum arrangement is intended to combine pharmacy dispensing with clinical programs, adherence, utilization management, and patient engagement; further programs of this type are planned.
Restricted networks remained a small, stable market; if they expand, the integrated clinical, pharmacy, infusion, and long-term-care offering was expected to support share gains.
MinuteClinic's lower-cost care can complement pharmacy network access, creating a broader patient-care proposition for health plans.
Latest events from CVS Health
- Separation aims to unlock standalone growth while preserving investment-grade balance sheets.CVS
8th Annual Wolfe Research Healthcare Conference - Care delivery expansion and post-deleveraging capital choices shape the forward strategy.CVS
30th Annual Credit Suisse Healthcare Conference - PBM cost controls, health plan growth and integrated care underpin the outlook.CVS
The 2016 Morgan Stanley Global Healthcare Conference - Integrated pharmacy scale supported growth and more than $5B in planned 2016 shareholder returns.CVS
The UBS 2016 Global Healthcare Conference - Signify bolsters in-home care and value-based strategy amid stable utilization.CVS
Morgan Stanley 20th Annual Global Healthcare Conference - Aetna integration targets >$750M in 2020 synergies and broader medical-cost savings.CVS
JP Morgan 37th Annual Healthcare conference - Cost savings and payer partnerships support long-term growth and shareholder returns.CVS
Investor Day 2016 - A $77B Aetna deal targets integrated care and $750M in year-two synergies.CVS
M&A announcement - FY18 operating profit growth guided to 1%–4%, tempered by PBM and deal-related headwinds.CVS
Guidance